3-6 February 2026 Dublin
| 3-PT | ´Long-term survival of total hip and total knee arthroplasty in people with haemophilia´ | Gijs Aertssen | |
| 3-PO | UK NEQAS BC survey outcome of the laboratory measurement of Altuvoct (efanesoctocog alfa) samples using an in vitro-spiked product specific calibrator. | Anna Williams | |
| 3-NUR | Impact of New Hemophilia Therapies on Therapeutic Patient Education: A Survey of French Nurses | Nicolas Guerin | |
| 4-NUR | A Nurse-Led Multidisciplinary Approach to post-infusion Gene Therapy Management | Deirdre Gorman | |
| 34-PO | In Vivo Assessment of the Procoagulant Effects of Recombinant Factor IX Concentrates During Emicizumab Therapy in a Hemophilia A Mouse Model | NORA Butta Coll | |
| 38-PO | Comparison of extravascular distribution between three extended half-life factor IX (EHL-FIX) concentrates utilising physiology-based pharmacokinetic (PBPK) modelling | Sjoerd Koopman | |
| 124-PO | EXPERIENCE IN THE DIAGNOSIS AND PROPHYLAXIS OF SEVERE HEMOPHILIA A DUE TO A DE NOVO MUTATION IN A SINGLE CENTER | Carmen Gil Barroso | |
| 128-PO | Analysis of Bone Density in People with Haemophilia: A single centre comparison of Severity Levels | Stephanie Taylor | |
| 147-PO | Disease Burden and Unmet Medical Need in Severe Hemophilia in Greece: Insights from Clinicians and Patients. | Nikoletta Sofiaki | |
| 194-PO | The first UK case report of successful haemodialysis in a person with severe haemophilia B receiving extended half-life factor IX prophylaxis | Natasha Wetherall | |
| 243-PO | Management of the preconception phase, pregnancy, and childbirth in women with Glanzmann thrombasthenia: findings from the European Association of Haemophila and Allied Disorders survey | Karlijn Rutten | |
| 250-PO | Evaluation of Fibrinolysis Testing Methods in Haemostasis and Thrombosis Laboratories: Results of a National Survey by the Spanish Society on Thrombosis and Haemostasis (SETH) Laboratory Working Group | NORA Butta Coll | |
| 251-PO | Safety of intramuscular vaccinations in children with inherited platelet disorders | Annick Moor | |
| 294-PO | Approaches across the spectrum in congenital factor X deficiency: real-world lessons from a 31-Year Single-Centrer experience. | Saverio Pancetti | |
| 304-PO | Familial factor V deficiency. An undocumented mutation. | Fernando Vazquez Lagos | |
| 315-PO | Implementation and evaluation of questionnaires to Review Problematic Menstrual Bleeding and Its Impact on Quality of Life. | Janet Cleary | |
| 324-PO | ´Predicting recovery after joint bleeding in persons with bleeding disorders´ | Gijs Aertssen | |
| 340-PO | A glance back as we move forward: The shifting paradigm of paediatric psychological care in haemophilia – a review of referrals to a paediatric psychology service over a decade. | Yvonne Duane | |
| 349-PO | Home delivery for medication specialising in the treatment of haemophilia and other coagulopathies in Madrid, Spain | Lourdes Pérez | |
3-6 February 2026 Dublin

Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|
|